Time to breathe: How COVID-19 interacts with interstitial lung disease

Katherine Myall (London, United Kingdom) & Emer Kelly (Dublin, Ireland)

Source: Short video discussion 2022
Number: 21

Video

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Katherine Myall (London, United Kingdom) & Emer Kelly (Dublin, Ireland). Time to breathe: How COVID-19 interacts with interstitial lung disease. Short video discussion 2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin?
Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
Year: 2020


Time as the fourth dimension of radiology: a patient with diffuse lung disease (interstitial lung disease)
Source: International Congress 2016 – GR2 Radiology
Year: 2016


Is it possible to predict the outcome of the whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP)?
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 6
Year: 2014

Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS)
Source: International Congress 2014 – Innovative technology and techniques in respiratory function
Year: 2014

What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Whole lung lavage efficacy in pulmonary alveolar proteinosis (PAP) is influenced by the infusion volume?
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash?
Source: Eur Respir J 2011; 37: 757-759
Year: 2011


Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Determining why patients with idiopathic pulmonary fibrosis (IPF) have difficulty performing gas transfer
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013


Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean?
Source: Eur Respir J, 55 (6) 2000894; 10.1183/13993003.00894-2020
Year: 2020



Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016

Changes in pulmonary gas exchange in histiocytosis X patients depending on the type of ventilation disorders
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water
Source: Eur Respir J 2013; 41: 781-783
Year: 2013


Multidisciplinary board for interstitial lung disease: Relevance for real life?
Source: International Congress 2015 – New insights into IIPs
Year: 2015


What is significant sleep disordered breathing in patients with interstitial lung disease?
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment
Source: International Congress 2016 – IPF treatment I
Year: 2016